INS and type 1 diabetes mellitus: A total of 15 adolescents enrolled in the program: median age 15.4 (IQR 14.5-16.4; range 14.1-19.7) years, mixed-sex (2 nonbinary, 6 females, and 7 males), median hemoglobin A1c level of 7.8% (IQR 7.4%-11.2%; range 6.2%-12.5%), average T1D diagnosis duration 8.2 (SD 3.8; range 2.6-14.6) years, and used automated insulin delivery (AID, n=3), a sensor-augmented pump (SAP, n=11), or multiple daily injections (MDIs) on a basal-bolus regimen (n=1).